#ITI#In vitro analysis of a hammerhead ribozyme targeted to infectious bronchitis virus nucleocapsid mRNA#FTI#
#IRE#Hammerhead ribozymes are catalytic RNA molecules that specifically cleave a target RNA molecule. Herein, we report the design, synthesis, and in vitro analysis of a hammerhead ribozyme targeted to the infectious bronchitis virus (IBV) nucleocapsid mRNA. At a concentration of 0.5 or 10 μM, the ribozyme, designated IBV-N-Rz, effectively cleaved target RNAs in trans (37 C, 10 mM MgCl2, 50 mM Tris). Cleavage products were visualized by agarose gel analysis. The time course of the ribozyme reaction was monitored by agarose gel analysis and relative quantitative reverse transcription-polymerase chain reaction. The amount of target RNA continually declined over a 5-hr period, indicating that the ribozyme was truly catalytic. Although stability and delivery problems must be overcome, a hammerhead ribozyme targeted to the IBV nucleocapsid mRNA most likely has antiviral activity and may be an effective therapeutic/prophylactic reagent in the future.#FRE#
#IPC#Antiviral; Hammerhead ribozyme; Infectious bronchitis virus; MFOLD; Nucleocapsid mRNA#FPC#
#IRF#Akin A., Lin T.L., Wu C.C., A ribozyme targeted to RNA polymerase gene of infections bursal disease virus effectively cleaves and inhibits expression of the viral gene product, Acta Virol, 43, pp. 341-347, (1999); 
Albuquerque-Silva J., Milican F., Bollen A., Houard S., Ribozyme-mediated decrease in mumps virus nucleocapsid mRNA level and progeny in infected vero cells, Antisense Nucleic Acid Drug Dev, 9, pp. 279-288, (1999); 
Altman S., Kirsebom L., Talbot S., Recent studies of ribonuclease p, FASEB J, 7, pp. 7-14, (1993); 
Baric R.S., Nelson G.W., Fleming J.O., Deans R.J., Keck J.G., Casteel N., Stohlman S.A., Interactions between coronavirus nucleocapsid protein and viral RNAs: Implications for viral transcription, J. Virol., 62, pp. 4280-4287, (1988); 
Belinsky M., Dinter-Gottlieb G., Characterizing the self-cleavage of a 135 nucleotide ribozyme from genomic hepatitis delta virus, Prog. Clin. Biol. Res., 364, pp. 265-274, (1991); 
Burke J.M., Clearing the way for ribozymes, Nat. Biotechnol., 15, pp. 414-415, (1997); 
Callison S.A., Jackwood M.W., Hilt D.A., Molecular characterization of infectious bronchitis virus isolates foreign to the United States and comparison with United States isolates, Avian Dis., 45, pp. 492-499, (2001); 
Cech T.R., RNA as an enzyme, Sci. Am., 255, pp. 64-75, (1986); 
Cologna R., Spagnolo J.F., Hogue B.G., Identification of nucleocapsid binding sites within coronavirus-defective genomes, Virology, 277, pp. 235-249, (2000); 
Compton S.R., Rogers D.B., Holmes K.V., Fertsch D., Remenick J., McGowan J.J., In vitro replication of mouse hepatitis virus strain A59, J. Virol., 61, pp. 1814-1820, (1987); 
Dalton K., Casais R., Shaw K., Stirrups K., Evans S., Britton P., Brown T.D., Cavanagh D., Cis-acting sequences required for coronavirus infectious bronchitis virus defective-RNA replication and packaging, J. Virol., 75, pp. 125-133, (2001); 
Doherty E.A., Doudna J.A., Ribozyme structures and mechanisms, Annu. Rev. Biochem., 69, pp. 597-615, (2000); 
Epstein L.M., Gall J.G., Self-cleaving transcripts of satellite DNA from the newt, Cell, 48, pp. 535-543, (1987); 
Ferbeyre G., Smith J.M., Cedergren R., Schistosome satellite DNA encodes active hammerhead ribozymes, Mol. Cell Biol., 18, pp. 3880-3888, (1998); 
Hammann C., Tabler M., Generation and application of asymmetric hammerhead ribozymes, Methods, 18, pp. 273-280, (1999); 
Jackson Jr. W.H., Moscoso H., Nechtman J.F., Galileo D.S., Garver F.A., Lanclos K.D., Inhibition of HIV-1 replication by an anti-tat hammerhead ribozyme, Biochem. Biophys. Res. Commun., 245, pp. 81-84, (1998); 
Jungherr E.L., Chomiak F.W., Luginbuhl R.E., Proceedings from the 60th Annual Meeting of the U.S.L.S.A., pp. 203-209, (1956); 
King D.J., Cavanagh D., Infectious bronchitis, Diseases of Poultry, pp. 471-484, (1991); 
Liu Y.C., Chou Y.C., Formaldehyde in formaldehyde/agarose gel may be eliminated without affecting the electrophoretic separation of RNA molecules, Biotechniques, 9, (1990); 
Macejak D.G., Jensen K.L., Jamison S.F., Domenico K., Roberts E.C., Chaudhary N., Von Carlowitz I., Bellon L., Tong M.J., Conrad A., Pavco P.A., Blatt L.M., Inhibition of hepatitis c virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes, Hepatology, 31, pp. 769-776, (2000); 
Maeda A., Hayashi M., Mizutani T., Ishida K., Watanabe T., Namioka S., Inhibition of viral multiplication in cells chronically infected with mouse hepatitis virus by antisense RNA against the polymerase gene, J. Vet. Med. Sci., 57, pp. 563-565, (1995); 
Maeda A., Mizutani T., Hayashi M., Watanabe I., Nainioka S., Inhibition of viral multiplication by hammerhead ribozymes targeted against the polymerase gene of mouse hepatitis virus, J. Vet. Med. Sci., 56, pp. 939-945, (1994); 
Mathews D.H., Sabina J., Zuker M., Turner D.H., Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure, J. Mol. Biol., 288, pp. 911-940, (1999); 
Senne D.A., Virus propogation in embryonating eggs, A Laboratory Manual for the Isolation and Identification of Avian Pathogens, pp. 235-240, (1998); 
Xing Z., Whitton J.L., Ribozymes which cleave arenavirus RNAs: Identification of susceptible target sites and inhibition by target site secondary structure, J. Virol., 66, pp. 1361-1369, (1992); 
Xing Z., Whitton J.L., An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield, J. Virol., 67, pp. 1840-1847, (1993); 
Zhou M., Collisson E.W., The amino and carboxyl domains of the infectious bronchitis virus nucleocapsid protein interact with 3′ genomic RNA, Virus Res., 67, pp. 31-39, (2000); 
Zuker M., Mfold web server for nucleic acid folding and hybridization prediction, Nucleic Acids Res., 31, pp. 3406-3415, (2003)#FRF#
